InvestorsHub Logo
Followers 16
Posts 2145
Boards Moderated 0
Alias Born 01/31/2014

Re: mrmainstreet post# 238311

Friday, 01/03/2020 6:37:01 AM

Friday, January 03, 2020 6:37:01 AM

Post# of 423952
No. The defendants have something to lose too. If they press thru the trial and lose they suffer the following.

1. Likely to be ordered to pay Amarin millions in court costs.

2. They will be forced to wait 9 months longer than Teva, who did settle, to enter the US market. Presumably the market will be mature and worth between $2 and $10 billion dollars annually. Teva would have the opportunity to convert much of that to their generic before Defendants could get their first script. Also assuming automatic refills this is a potential for Defendants to miss out on massive $$$.

This game of chicken will only go on for a bit longer. IMO there is close to zero chance the Defendants will roll the dice considering they will lose the trail.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News